[Biological response modifiers and cancer treatment].
Urushizaki
I
I
D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007372:Interferons / Q000627:therapeutic use; D007375:Interleukin-1 / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000637:transplantation; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D003115:Colony-Stimulating Factors; D007375:Interleukin-1; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons